Kowa ya san cewa ciwon huhu, ciwon ciki, ciwon hanji, da ciwon nono suna da sauƙin dubawa ta hanyar duba lafiyar jiki, don haka masu ciwon daji da aka gano da wuri suna da kyakkyawan hangen nesa kuma tsawon rayuwarsu yana da tsawo.
However, liver cancer, another serious life-threatening cancer that accounts for more than 55% of the world’s cancers in China, is difficult to be diagnosed early. Most patients are diagnosed late and lose the chance of surgery. Although other treatments are diverse, it is difficult to maintain long-term survival. The early diagnosis of ciwon daji has always been a difficult problem in the tumor world.
A wannan karon, nasarar da masana kimiyyar kasar Sin suka samu ya cancanci alfaharinmu musamman!
A ranar 12 ga Maris, shirin Cibiyar Nazarin Kimiya ta Amurka (PNAS) ta fitar da DNA (cfDNA) da alamomin furotin da ba su da tantanin halitta wanda Cibiyar Ciwon daji ta kasa, da Asibitin Ciwon daji na Kwalejin Kimiyyar Kiwon Lafiya ta kasar Sin da Beijing Panshengzi Gene Technology Co. ., Ltd. Sakamako na farkon gwajin cutar kansar hanta a cikin ƙungiyar masu ɗaukar HBV masu zuwa.
Binciken ya yi amfani da hanyar biopsy na ruwa na maye gurbi na cfDNA hade da alamomin furotin da masana kimiyyar kasar Sin suka kirkira da kansu-HCCscreen. Bayan tabbataccen tabbaci na asibiti, ana sa ran za a yi amfani da sakamakon binciken don fara gwajin cutar kansar hanta.
A cikin wannan binciken, ana iya samun ciwon hanta na farko da bai wuce 3 cm ba. Masu binciken sun sami samfuran jini na gefe na maye gurbi na DNA maras tantanin halitta da alamomin furotin, kuma sun gwada masu ɗaukar HBV 331 tare da sakamakon alpha-fetoprotein na al'ada da sakamakon B-ultrasound.
An gano sakamakon 24 lokuta (watakila tare da ciwon hanta), kuma a cikin watanni 6 zuwa 8 da suka biyo baya, an gano lokuta 4 suna da ciwon hanta. Sauran marasa lafiya 307 ba su da kyau kuma ba a sami ciwon hanta ba yayin lokacin biyo baya. Cimma hankali 100%, ƙayyadaddun 94% da ƙimar tsinkayar 17% tabbatacce.
Early-stage liver cancer can be detected by blood testing from asymptomatic HBV carriers. This technology can achieve accurate detection of common mutations in liver cancer such as cfDNA point mutations, insertion deletion mutations, and HBV virus integration. At present, the research method has been further optimized, the sensitivity is stable at more than 93%, and the specificity can be increased to more than 98%.
Duk da haka, a halin yanzu, wannan fasaha har yanzu tana cikin matakin bincike, kuma har yanzu ba a amince da ita a hukumance don gwajin asibiti don gwajin ciwon hanta da wuri ba. Koyaya, mutanen da ke da babban haɗari ko buƙatar gwajin cutar kansa da wuri za su iya zaɓar zuwa asibiti na yau da kullun ko wurin gwajin likita don duba lafiyar cutar kansa da wuri!
A halin yanzu, mutane da yawa a China suna son tafiya da siyayya a Japan. Af, kammala cikakken gwajin likita, gami da fara gwajin cutar kansa daban-daban, kuma ku ba wa kanku kwanciyar hankali yayin wasa, don tabbatar da lafiyayyen jiki.
